Seattle, WA: Active ingredients in cannabis provide therapeutic properties that may be clinically useful in the treatment of neurologic disorders, according to a review published in the journal Physical Medicine and Rehabilitation Clinics of North America.
Researchers at the University of Washington School of Medicine determined: “Cannabinoids have the capacity for neuromodulation through direct, receptor-based mechanisms at many levels within the nervous system, providing therapeutic properties that may be applicable to the treatment of neurologic disorders. These include antioxidation, neuroprotection, analgesia, anti-inflammation, immunomodulation, modulation of glial cells, and tumor growth regulation.
Full text of the study appears in the November issue of the journal.
For more information, please contact Paul Armentano, NORML Senior Policy Analyst, at (202) 483-5500.